List of Excipients in API ofloxacin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ofloxacin
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Allergan Inc | OCUFLOX | ofloxacin | 11980-779 | BENZALKONIUM CHLORIDE | |
Allergan Inc | OCUFLOX | ofloxacin | 11980-779 | HYDROCHLORIC ACID | |
Allergan Inc | OCUFLOX | ofloxacin | 11980-779 | SODIUM CHLORIDE | |
Allergan Inc | OCUFLOX | ofloxacin | 11980-779 | SODIUM HYDROXIDE | |
Allergan Inc | OCUFLOX | ofloxacin | 11980-779 | WATER | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing ofloxacin
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 | BENZALKONIUM CHLORIDE |
Henry Schein Inc | ofloxacin | 0404-7189 | HYDROCHLORIC ACID |
Henry Schein Inc | ofloxacin | 0404-7189 | SODIUM CHLORIDE |
Henry Schein Inc | ofloxacin | 0404-7189 | SODIUM HYDROXIDE |
Henry Schein Inc | ofloxacin | 0404-7189 | WATER |
American Regent Inc | ofloxacin | 0517-0760 | BENZALKONIUM CHLORIDE |
American Regent Inc | ofloxacin | 0517-0760 | HYDROCHLORIC ACID |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for ofloxacin
Excipient focus: ANHYDROUS LACTOSE
ofloxacin drug variants containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Larken Laboratories Inc | ofloxacin | 68047-713 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing ANHYDROUS LACTOSE
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: BENZALKONIUM CHLORIDE
ofloxacin drug variants containing BENZALKONIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: BUTYL ALCOHOL
ofloxacin drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
ofloxacin drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
ofloxacin drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
ofloxacin drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Larken Laboratories Inc | ofloxacin | 68047-713 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
ofloxacin drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Larken Laboratories Inc | ofloxacin | 68047-713 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
ofloxacin drug variants containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Larken Laboratories Inc | ofloxacin | 68047-713 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
ofloxacin drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Larken Laboratories Inc | ofloxacin | 68047-713 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
ofloxacin drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
ofloxacin drug variants containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
ofloxacin drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ofloxacin drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Larken Laboratories Inc | ofloxacin | 68047-713 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
ofloxacin drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
ofloxacin drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Larken Laboratories Inc | ofloxacin | 68047-713 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
ofloxacin drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Larken Laboratories Inc | ofloxacin | 68047-713 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
ofloxacin drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
ofloxacin drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
ofloxacin drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
ofloxacin drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Larken Laboratories Inc | ofloxacin | 68047-713 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
ofloxacin drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Larken Laboratories Inc | ofloxacin | 68047-713 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
ofloxacin drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Larken Laboratories Inc | ofloxacin | 68047-713 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
ofloxacin drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Larken Laboratories Inc | ofloxacin | 68047-713 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
ofloxacin drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ofloxacin drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Dr Reddy's Laboratories Limited | ofloxacin | 55111-160 |
Larken Laboratories Inc | ofloxacin | 68047-713 |
Cadila Pharmaceuticals Limited | ofloxacin | 71209-097 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-120 |
Nivagen Pharmaceuticals Inc | ofloxacin | 75834-199 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
ofloxacin drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Henry Schein Inc | ofloxacin | 0404-7189 |
American Regent Inc | ofloxacin | 0517-0760 |
Allergan Inc | ofloxacin | 11980-779 |
MWI | ofloxacin | 13985-602 |
STAT RX LLC USA | ofloxacin | 16590-175 |
STAT RX USA LLC | ofloxacin | 16590-931 |
Akorn | ofloxacin | 17478-713 |
>Company | >Ingredient | >NDC |
ofloxacin drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.